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Discussion: Although experience with EUS-guided biliary 
drainage is still limited, its efficacy and safety is favorable 
when compared with percutaneous and surgical drainage, 
and should be considered an alternative to these techniques 
where sufficient expertise exists. 
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Resumo
Introdução: A colangiopancreatografia retrógrada en-
doscópica é o procedimento de escolha para a drenagem 
biliar, embora em alguns casos o acesso biliar convencio-
nal é difícil ou até impossível. As técnicas de drenagem 
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Abstract
Introduction: Endoscopic retrograde cholangiopancreatog-
raphy is the method of choice for biliary drainage, although 
in some cases standard biliary access is difficult or even im-
possible. Endoscopic ultrasound (EUS)-guided endoluminal 
procedures are an alternative in these cases, although expe-
rience with these techniques is still limited. Clinical Case: We 
present two cases of successful EUS-guided biliary drainage. 
In the first case, a hepaticogastrostomy was performed in a 
patient with stage IV gastric adenocarcinoma with obstruc-
tive jaundice due to compression of the hilum, where malig-
nant gastric stenosis and previous palliative gastrojejunos-
tomy precluded access to the second part of the duodenum. 
In the second case, a patient with a pancreatic head adeno-
carcinoma with duodenal invasion that precluded major pa-
pillae identification was submitted to a choledochoduode-
nostomy. Both procedures occurred without immediate or 
delayed adverse events, with technical and clinical success. 
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guiadas por ecoendoscopia são uma alternativa nestes 
casos, embora a experiência seja ainda limitada. Caso: 
Apresentamos dois casos de drenagem biliar eficaz guia-
da por ecoendoscopia. No primeiro caso foi realizada he-
paticogastrostomia numa doente com adenocarcinoma 
gástrico estadio IV, com icterícia obstrutiva devido a com-
pressão hilar pela neoplasia, na qual o acesso à segunda 
porção duodenal se revelou impossível devido à neopla-
sia gástrica estenosante e a antecedentes de gastrojeju-
nostomia paliativa. No segundo caso, uma doente com 
adenocarcinoma cefalo-pancreático com invasão duode-
nal que impedia a identificação da papila foi submetida a 
coledocoduodenostomia. Em ambos os procedimentos 
foi conseguida drenagem biliar eficaz e não ocorreram 
eventos adversos imediatos ou tardios. Discussão: Apesar 
de a experiência com técnicas de drenagem biliar guiadas 
por ecoendoscopia ser limitada, o seu perfil de eficácia e 
segurança parece ser favorável quando comparada com 
as alternativas (drenagem percutânea ou cirúrgica), pelo 
que devem ser consideradas quando exista equipamento 
e experiência necessária. 
© 2017 Sociedade Portuguesa de Gastrenterologia 
Publicado por S. Karger AG, Basel
Introduction
Endoscopic retrograde cholangiopancreatography 
(ERCP) is the method of choice for biliary endotherapy, 
including drainage in obstructive jaundice. However, 
there are some patients in whom biliary access is difficult 
or impossible even in expert hands, due to luminal ob-
struction or surgically modified anatomy (e.g., Roux- 
en-Y gastrojejunostomy). When faced with difficulties in 
achieving deep biliary cannulation, clinicians need alter-
native techniques to allow minimally invasive biliary 
therapy. The approaches available to overcome these 
ERCP limitations include endoscopic ultrasound (EUS)-
guided endoluminal procedures, balloon-assisted ERCP, 
percutaneous techniques or surgery, each one with ad-
vantages, drawbacks, and different availability. The per-
cutaneous approach is generally more available, but is 
also associated with a significant risk of adverse events, 
and is sometimes associated with permanent or tempo-
rary external biliary drainage that can impair patients’ 
quality of life [1]. On the other hand, EUS-guided proce-
dures have the advantage of being entirely performed in-
traluminally. EUS-guided therapy includes direct trans-
gastric or transduodenal stenting, rendezvous techniques, 
and anterograde transpapillary stent insertion, although 
experience with these techniques is still limited [2]. We 
report and describe two cases of successful biliary decom-
pression through direct transluminal stenting using EUS 
guidance. 
Clinical Cases
Case 1 – EUS-Guided Hepaticogastrostomy
We report the case of a 60-year-old female patient with stage IV 
adenocarcinoma of the gastric antrum previously submitted to pal-
liative gastrojejunostomy, and obstructive jaundice due to malig-
nant compression of the hepatic hilum by the gastric neoplasm. The 
patient presented with obstructive jaundice (total bilirubin 13.2 
mg/dL) and CT scan showed severe dilation of the intrahepatic bil-
iary tree caused by obstruction at the hepatic hilum. A gastric self-
expandable noncovered metal stent (Wallflex 22/90 mm; Boston 
Scientific, Marlborough, MA, USA) was initially placed to allow the 
passage of the duodenoscope through the stenosis. The distal ex-
tremity of the stent was placed in the duodenal bulb with the aim 
of not impairing access to the papilla, but the second portion of the 
duodenum could not be reached due to anatomical deformation 
caused by the tumor and the surgical history. After multidisci-
plinary discussion and patient information about the palliative 
therapeutic alternatives, EUS-guided drainage was decided. EUS 
was then performed with a linear therapeutic echoendoscope (Pen-
tax, EG-3870UTK) and intrahepatic biliary duct dilation was con-
firmed. With the echoendoscope positioned in the upper part of the 
lesser curvature, a peripheral intrahepatic bile duct was punctured 
with a 19-G needle (Expect, Boston Scientific) (Fig. 1a). The success 
of the biliary puncture was confirmed after observing bile in the 
needle aspirate, followed by contrast injection into the biliary tree. 
A 450-cm-long, 0.035-inch guidewire (Jagwire Stiff STTM, Boston 
Scientific) was then advanced through the needle to the intrahe-
patic ducts, followed by dilation of the tract with a 6-Fr cystotome 
(Cysto Gastro Set; Endoflex, GmbH, Voerde, Germany; endocut Q; 
40 W; effect 1). A self-expandable fully covered metal stent (Evolu-
tion Biliary 10/60 mm, Cook Medical, Bloomington, IN, USA) was 
then placed from the left intrahepatic duct to the stomach without 
adverse events (Fig. 1b). Finally, a plastic double pigtail biliary stent 
(Zimmon 10 Fr × 10 cm, Cook Medical) was placed inside the met-
al stent to reduce the risk of stent migration (Fig. 1c, d). One day 
after the procedure, the patient developed fever and antibiotherapy 
(piperacillin/tazobactam) was prescribed for 5 days, after hemocul-
tures were obtained (that revealed to be negative). The fever ceased 
after 2 days of antibiotherapy, and the patient was discharged 5 days 
after the procedure without jaundice and without other symptoms. 
The patient died 2 months after the procedure without related ad-
verse events or jaundice recurrence. 
Case 2 – EUS-Guided Choledochoduodenostomy
A 66-year-old female was admitted due to obstructive jaundice 
(total bilirubin 15.4 mg/dL, direct 8.2 mg/dL) and weight loss, and 
a pancreatic head cancer was diagnosed. CT scan and EUS showed 
dilation of the common and intrahepatic bile ducts, a pancreatic 
mass with vascular invasion (mesenteric and portal veins) and re-
gional adenopathies. EUS-FNA revealed a pancreatic adenocarci-
noma. The disease was considered nonresectable and the patient 
was proposed for palliative chemotherapy, although biliary drain-
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age was necessary before treatment initiation. An ERCP was first 
attempted but standard access to the biliary tree was not possible 
due to nonidentification of the papilla associated with duodenal 
invasion. EUS-guided biliary drainage was then decided after mul-
tidisciplinary team evaluation. The dilated common bile duct was 
punctured by a transbulbar approach with a 19-G needle (Expect, 
Boston Scientific) and the cholangiogram performed revealed a 
tight stenosis in the distal portion of the biliary tree (Fig. 2a). A 
450-cm-long, 0.035-inch guidewire (JagwireTM, Boston Scientific) 
was advanced through the needle (Fig. 2b) and the tract was di-
lated with a 6-Fr cystotome (Cysto Gastro Set; Endoflex, GmbH; 
endocut 40 W/effect 1). A diablo-shaped self-expandable fully cov-
ered metal stent with 20 mm (usable length) × 14/26 mm (lumen/
flanges) (Diagmed Healthcare; Thirsk, UK) was finally inserted 
and deployed, connecting the common bile duct to the duodenal 
bulb, with successful biliary drainage and without immediate ad-
verse events (Fig. 2c, d). This was followed by resolution of jaun-
dice, and the patient was able to initiate palliative chemotherapy. 
No late adverse events occurred during the 4 months’ follow-up 
and the patient is still alive on chemotherapy. 
a b
c d
Fig. 1. a Puncture of the left intrahepatic bile duct with a 19-G needle. b A 10 × 60 mm fully covered self-expand-
able metal stent was placed connecting a left intrahepatic bile duct with the stomach. c A double pigtail plastic 
stent with a 10-cm length was placed inside the metal stent to reduce the risk of stent migration. d Final endo-
scopic view of hepaticogastrostomy.
EUS-Guided Biliary Drainage in Difficult 
Biliary Access




In recent years, EUS-guided biliary drainage has 
emerged as an alternative to percutaneous and surgical 
drainage in cases where ERCP techniques are difficult or 
not possible [2]. Here we present two cases of successful 
EUS-guided biliary drainage through hepaticogastrosto-
my and choledochoduodenostomy. In the first case, 
ERCP was not possible due to gastric outlet obstruction 
and surgical modified anatomy and in the second, pan-
creatic head cancer invasion into the duodenum wall pre-
cluded papilla identification. In both cases, biliary drain-
age was attained with the insertion of self-expandable 
metal stents connecting the biliary tree with the stomach 
in the first case, and the duodenal bulb in the second. In 
the hepaticogastrostomy case, a plastic biliary stent was 
also placed inside the metal stent to decrease the risk of 
stent migration. The stents used were chosen based on 
anatomical considerations, operators’ experience as well 
as availability, since there are no comparative studies 
evaluating the outcomes of different stent types, due to 
the novelty of these techniques and the limited number of 
a b
c d
Fig. 2. a EUS-guided choledochal puncture with a 19-G needle. b Guidewire passage to the common bile duct. 
c Diablo-shaped fully covered self-expandable metal stent was placed connecting the choledochus with the duo-
denal bulb. d Final endoscopic view of the distal end of the stent in the bulb. 
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cases reported. In the first case, a standard fully covered 
biliary self-expandable metal stent was chosen because 
diablo-shaped stents are not adequate for left hepatico-
gastrostomy, as a result of their shorter length and large 
luminal diameter. We used a stent-in-stent technique 
(with a longer plastic stent inside the fully covered self-
expandable metal stent) to decrease the risk of stent mi-
gration. An alternative to this approach would be the 
placement of a dedicated half-covered and half-uncov-
ered stent designed specifically for hepaticogastrostomy 
that was recently evaluated in a retrospective study in-
cluding 41 patients, although migration still occurred in 
4.9% [3]. Diablo-shaped stents, although not appropriate 
for hepaticogastrostomy, can be used in choledochoduo-
denostomies where its shape is adequate for appropriate 
fixation of the duodenal and common bile duct walls. Re-
cently developed lumen-apposing stents designed specif-
ically for biliary drainage are also an option, making this 
procedure apparently simpler, since tract dilatation is not 
needed with these devices.
As previously stated, EUS-guided biliary drainage is 
emerging as an alternative to conventional percutaneous 
and surgical drainage, although experience with these 
techniques and their availability is still limited, and com-
parative studies with conventional techniques are scarce. 
Even though, EUS-guided drainage seems promising 
since according to a recent meta-analysis successful bili-
ary drainage is achieved in 93% of the cases, although the 
rate of adverse events is not negligible (17% overall) [1]. 
Bile leak is the most frequent adverse event, although oth-
er early and late complications can occur. Early complica-
tions include cholangitis, bleeding, stent misplacement, 
and bile leaks [4]. Dilation of the tract before stent inser-
tion is recommended to decrease the risk of bile leaks 
since it avoids frequent device exchange and decreases 
procedural time. A cystotome seems to be the instrument 
of choice to perform the dilation since it was associated 
with a higher rate of technical success [5], although biliary 
dilation catheters can also be used. Late complications in-
clude stent malfunction due to occlusion as well as stent 
migration, which has a poor prognosis. For hepaticogas-
trostomy, long stents may decrease the risk of stent mi-
gration. Indeed, a stent length ≥3 cm in the intraluminal 
portion was shown to be associated with a lower risk of 
stent migration in a retrospective study including 51 pa-
tients [6] and a small study including 4 patients reported 
no migration when ≥10 cm stents (total length) were used 
[4]. Choosing a stent with a large diameter is also impor-
tant to decrease the risk of stent dysfunction due to gran-
ulation tissue in the hepatic side of the stent, although the 
ideal diameter is not well established. Diablo-shaped 
stents also seem to decrease this risk of stent migration in 
choledochoduodenostomy and should be used in these 
cases. 
Regarding the comparison between EUS-guided 
drainage and percutaneous drainage, EUS techniques 
seem to have a better efficacy and safety profile. Indeed, 
according to a recent systematic review and meta-analy-
sis, it was associated with a significantly lower rate of 
drainage failure (OR 0.45, 95% CI 0.23–0.89), post-pro-
cedural adverse events (OR 0.23, 95% CI 0.12–0.47) and 
need for reintervention (OR 0.13, 95% CI 0.07–0.24) [1]. 
Bile leak was the most frequent adverse event, occurring 
in 10% of the patients undergoing transcutaneous drain-
age (vs. 3% in EUS-guided drainage). Rates of procedure-
related bleeding, cholangitis, sepsis, and peritonitis were 
also slightly higher with the percutaneous approach, 
while procedure-related death was similar between 
groups. EUS-guided drainage has also the probable ad-
vantage of being associated with a better quality of life 
since the drainage is always performed without external 
drains. Although surgical drainage is also an option when 
minimally invasive procedures fail, to our knowledge 
there are no studies directly comparing the outcomes of 
EUS-guided and surgical biliary drainage. In a recent 
study, EUS-guided biliary drainage was also comparable 
with conventional transpapillary ERCP drainage in terms 
of clinical success, procedural time, and adverse events, 
being even associated with a lower rate of pancreatitis [7]. 
However, this was a small single-center study and stan-
dard ERCP has a demonstrated high efficacy and safety 
profile with experienced operators and should be the 
first-line approach to biliary drainage. Regarding patients 
with surgically altered anatomy, enteroscopy-assisted 
ERCP is also an alternative, although a recent multicen-
tric comparative study showed that EUS-guided biliary 
drainage is more effective and safe than enteroscopy-as-
sisted ERCP (technical success 98 vs. 65.3%, p = 0.0001; 
clinical success 88 vs. 59.1%, p = 0.03; adverse events 4 vs. 
20%, p = 0.01) [8].
Concerning the approach of biliary drainage, both the 
hepatogastric and choledochoduodenal approach seem 
to have comparable success in attaining biliary drainage, 
and there are still some controversies (in cases where both 
approaches are possible). Hepatogastric drainage was as-
sociated with a higher risk of complications in a recent 
review [9] and in a recent multicenter study, where cho-
ledochoduodenostomy was also associated with shorter 
inpatient stay and improved stent patency [10]. On the 
other hand, a comparative study between the two tech-
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niques showed a significantly longer stent patency with 
hepaticogastrostomy and a lower risk of adverse events 
[11]. Thus, as no definite conclusions exist concerning 
the best approach, for now the decision should be made 
on a case-by-case basis, taking also into account that in 
certain circumstances the decision is linked to patient-
related factors (e.g., hepaticogastrostomy is only possible 
if there is a significant dilation of the intrahepatic bile 
ducts, and choledochoduodenostomy may not be feasible 
in cases of duodenal invasion, gastric outlet obstruction, 
or surgically altered anatomy). 
In conclusion, we report two cases of successful EUS-
guided biliary drainage in cases where ERCP was not pos-
sible, raising the importance of training and availability 
of these techniques in order to provide the patients with 
the best treatment, although we recognize that these tech-
niques should only be performed wherever adequate ex-
pertise exists. 
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